BioFinland 05 April 26–27, 2005, Helsinki, Finland
BioFinland 05 is an international biotechnology congress focusing on Genomic Drug Discovery. The Congress will approach the entire drug chain from basic research to the patient.
Slide presentation (PDF).
The Investor Forum alongside the congress will offer an opportunity for promising biotech companies to meet investors and financiers.
An exhibition ChemBio Finland 05 arranged at the same time will highlight latest innovations and developments within chemical and biotechnology as well as laboratory analytics.
The previous international biotechnology event BioTech Helsinki 03 with Investor Forum and Exhibition gathered over 3,000 participants. Please look at some of the presentations at BioTech Helsinki 03.
Top-level expertise in Finland
Drug discovery has a central role in the research and development process of Finnish biotechnology. Pharmaceutical research has been a target for significant governmental and private investments in Finland. The long-term investments have created top-level research and technological know-how in the country. The goal is to strengthen and build up a world class innovation system for Finnish and international companies to operate.
